# Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single and Multiple Doses of LEO 142397 in Healthy People, Including Japanese

> **NCT03995550** · PHASE1 · WITHDRAWN · sponsor: **LEO Pharma**

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LEO 142397
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03995550
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-07-03
- **Primary completion:** 2020-01-27
- **Final completion:** 2020-07-16
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Portfolio proritisation
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03995550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03995550, "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single and Multiple Doses of LEO 142397 in Healthy People, Including Japanese". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03995550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*